Bafna Pharmaceuticals Limited (BAFNAPH) — Cash Flow Reinvestment Rate
Bafna Pharmaceuticals Limited (BAFNAPH) has a Cash Flow Reinvestment Rate of 1.76x as of September 2025, reinvesting Rs164.17 Million (capex Rs164.17 Million ) from operating cash flow of Rs93.12 Million. Explore Bafna Pharmaceuticals Limited (BAFNAPH) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bafna Pharmaceuticals Limited Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Bafna Pharmaceuticals Limited across 9 annual periods. Also explore Bafna Pharmaceuticals Limited (BAFNAPH) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Bafna Pharmaceuticals Limited (2007–2025)
Year-by-year capital reinvestment analysis for Bafna Pharmaceuticals Limited. For live market cap and broader valuation context, see market cap of Bafna Pharmaceuticals Limited.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.20x | Rs430.23 Million | Rs195.29 Million | Rs218.60 Million | ▼ -31.8% |
| 2024 | 3.23x | Rs306.32 Million | Rs94.85 Million | Rs155.78 Million | ▲ +1.8% |
| 2023 | 3.17x | Rs157.11 Million | Rs49.52 Million | Rs82.19 Million | ▲ +137.8% |
| 2022 | 1.33x | Rs129.80 Million | Rs97.28 Million | Rs75.41 Million | ▼ -47.3% |
| 2016 | 2.53x | Rs23.07 Million | Rs9.11 Million | Rs23.07 Million | ▲ +246.7% |
| 2015 | 0.73x | Rs77.90 Million | Rs106.65 Million | Rs77.90 Million | ▼ -33.1% |
| 2014 | 1.09x | Rs17.53 Million | Rs16.06 Million | Rs17.53 Million | ▲ +1778.7% |
| 2013 | 0.06x | Rs21.28 Million | Rs366.32 Million | Rs21.28 Million | ▼ -96.9% |
| 2007 | 1.85x | Rs187.01 Million | Rs101.06 Million | Rs187.01 Million | — |